Our data show that the frequency of CD8+ T cells specific for antigens expressed during the latent phase of the virus is significantly higher in CIS patients and in MS patients with shorter disease duration compared to other MS patients and to healthy donors, while the frequency of CD8+ T cells specific for antigens expressed during the lytic phase of the virus is significantly higher in patients undergoing clinical relapse compared to patients in the stable phase of the disease and healthy donors.